SYLENTIS

📍 Tres Cantos, Spain🗓 Founded 2006👥 31 employees💰 Last funded 2019
Biotechnology Research🌐 sylentis.com
Website LinkedIn
Sylentis is an European biotechnological company founded in 2006. Sylentis focuses on researching new therapeutic approaches based on gene silencing. Our company is specialised in developing ophtalmologic therapies via interference RNA, a powerful tool for rational drug design. Most advanced product of the company are treatments for glaucoma and dry eye syndrome. Sylentis is a wholly owned member of PharmaMar (www.pharmamar.com)
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2006
Founded

Investors

1 investor
All
Early stage
Mid stage
Late stage
Investor geography1 country
Spain
1
Frequently asked questions
Who invested in SYLENTIS?
SYLENTIS has 1 investor on record on gritt.io.
When did SYLENTIS last raise funding?
The most recent investment in SYLENTIS recorded on gritt.io was in 2019.
When was SYLENTIS founded?
SYLENTIS was founded in 2006.
What industry is SYLENTIS in?
SYLENTIS operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is SYLENTIS based?
SYLENTIS is headquartered in Tres Cantos, Spain.